1-(1,1-Dimethylethyl)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one, 97%, 25g

Methyl 2-amino-3-chloropropanoate hydrochloride, 95.0%, 1g

Etofylline>98.0%(HPLC)(N)25g

5-HYDROXYMETHYL-1-METHYL-1H-PYRIDIN-2-ONE, 95.0%, 1g

4-(m-Tolylamino)pyridine-3-sulfonamide, 95.0%, 10g

tert-Butyl ((3-chloro-5,6-dicyanopyrazin-2-yl)oxy)carbamate, 97%, 100mg

2,4-Dimethyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-oxazole, 98%, 50mg

Nitrato de sanguinarina, mínimo 95 %, 10 mg, envase de vidrio

ethyl 8-(2,5-difluorophenyl)-8-oxooctanoate, 97.0%, 1g

2-Amino-4-(4-pyridyl)thiazole, 97.0%, 25g

2-Fluoro-4-methoxy-5-nitroaniline, 97%, 100mg

1-Benzyl 3-ethyl 3-methylpiperidine-1,3-dicarboxylate, 95.0%, 250mg

Señales de obligación probadas en la práctica, 100 mm, 1 pieza